切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2013, Vol. 02 ›› Issue (02) : 80 -84. doi: 10.3877/cma.j.issn.2095-3216.2013.02.006

专家论坛

危重患者连续性肾脏替代治疗开始及停止治疗的时机
刘文虎1,()   
  1. 1.100050 首都医科大学附属北京友谊医院肾内科
  • 出版日期:2013-04-15
  • 通信作者: 刘文虎

The start and stop timing of continuous renal replacement therapy in critically ill patients

Wen-hu LIU1,()   

  1. 1.Department of Nephrology Affiliated Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
  • Published:2013-04-15
  • Corresponding author: Wen-hu LIU
引用本文:

刘文虎. 危重患者连续性肾脏替代治疗开始及停止治疗的时机[J/OL]. 中华肾病研究电子杂志, 2013, 02(02): 80-84.

Wen-hu LIU. The start and stop timing of continuous renal replacement therapy in critically ill patients[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2013, 02(02): 80-84.

连续性肾脏替代治疗(CRRT)是在间歇性血液透析基础上发展起来的一种新的血液净化技术。因其具有连续、缓慢清除溶质和血流动力学稳定等特点被广泛应用于各种危重症疾病的救治。笔者就近年来CRRT在临床的应用指征以及开始与终止治疗的时机做一综述。

Continuous renal replacement therapy (CRRT) is a newly developed method of blood purification technology, based on intermittent hemodialysis. It is widely used in the treatment of various critical care diseases due to its continuous and slow clearance of blood solute and hemodynamic stability.In this article, the indications for CRRT application and when to start or terminate the treatment are reviewed.

1
Clark E, Wald R, Levin A, et al. Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study [J]. Can J Anaesth,2012, 59(9): 861-870.
2
Dichtwald S, Weinbroum AA, Sorkine P, et al. Metforminassociated lactic acidosis following acute kidney injury.Efficacious treatment with continuous renal replacement therapy[J]. Diabet Med, 2012, 29(2): 245-250.
3
Fleming GM, Walters S, Goldstein SL, et al. Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group [J]. Pediatr Crit Care Med, 2012, 13(5): e299-304.
4
Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST) [J]. Int J Artif Organs,2002, 25(8): 733-747.
5
Oh HJ, Shin DH, Lee MJ, et al. Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury [J]. J Crit Care, 2012,27(6): 743. e9-18.
6
Garcia-Fernandez N, Perez-Valdivieso JR, Bes-Rastrollo M, et al. Timing of renal replacement therapy after cardiac surgery: a retrospective multicenter Spanish cohort study [J]. Blood Purif,2011, 32(2): 104-111.
7
Bagshaw SM, Uchino S, Bellomo R, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury [J]. J Crit Care, 2009, 24(2): 129-140.
8
Shiao CC, Ko WJ, Wu VC, et al. U-curve association between timing of renal replacement therapy initiation and in-hospital mortality in postoperative acute kidney injury [J]. PLoS One.2012, 7(8): e42952.
9
Seabra VF, Balk EM, Liangos O, et al. Timing of renal replacement therapy initiation in acute renal failure: a metaanalysis [J]. Am J Kidney Dis, 2008, 52(2): 272-284.
10
Bagshaw SM, Gibney RT. Conventional markers of kidney function [J]. Crit Care Med, 2008, 36(4): S152-158.
11
Carl DE, Grossman C, Behnke M, et al. Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure [J]. Hemodial Int, 2010, 14(1): 11-17.
12
De Corte W, Vanholder R, Dhondt AW, et al. Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy [J]. Nephrol Dial Transplant, 2011, 26(10): 3211-3218.
13
Brar H, Olivier J, Lebrun C, et al. Predictors of mortality in a cohort of intensive care unit patients with acute renal failure receiving continuous renal replacement therapy [J]. Am J Med Sci, 2008, 335(5): 342-347.
14
Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury [J]. Am J Kidney Dis, 2013, 61(5): 649-672.
15
Kumpers P, Hafer C, Lukasz A, et al. Serum neutrophil gelatinaseassociated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury[J]. Crit Care, 2010, 14(1): R9.
16
Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery [J]. Hemodial Int, 2004, 8(4):320-325.
17
Bagshaw SM, Wald R, Barton J, et al. Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational study [J]. J Crit Care, 2012, 27(3): 268-275.
18
Ostermann M, Dickie H, Barrett NA. Renal replacement therapy in critically ill patients with acute kidney injury--when to start [J].Nephrol Dial Transplant, 2012, 27(6): 2242-2248.
19
Vaara ST, Korhonen AM, Kaukonen KM, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study [J]. Crit Care, 2012, 16(5): R197.
20
Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis [J]. Crit Care Med, 2004, 32(8):1771-1776.
21
Heung M, Wolfgram DF, Kommareddi M, et al. Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury [J]. Nephrol Dial Transplan, 2012, 27(3): 956-961.
22
Shiao CC, Wu VC, Li WY, et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery [J]. Crit Care, 2009,13(5): R171.
23
Wu SC, Fu CY, Lin HH, et al. Late initiation of continuous venovenous hemofiltration therapy is associated with a lower survival rate in surgical critically ill patients with postoperative acute kidney injury [J]. Am Surg, 2012, 78(2): 235-242.
24
Schneider AG, Eastwood GM, Seevanayagam S, et al. A risk,injury, failure, loss, and end-stage renal failure score-based trigger for renal replacement therapy and survival after cardiac surgery [J].J Crit Care, 2012, 27(5): 488-495.
25
Choi KA, Lee JE, Kim YG, et al. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome [J]. Ann Hematol, 2009, 88(7): 639-645.
26
Vats HS, Dart RA, Okon TR, et al. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center [J]. Ren Fail, 2011, 33(7): 698-706.
27
Baird JS, Wald EL. Long-duration (> 4 weeks) continuous renal replacement therapy in critical illness [J]. Int J Artif Organs, 2010,33(10): 716-720.
28
Bouman CS, Oudemans-Van SHM, Tijssen JG, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial [J]. Crit Care Med, 2002, 30(10): 2205-2211.
29
Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study [J]. Crit Care Med,2009, 37(9): 2576-2582.
30
Gibney N, Hoste E, Burdmann EA, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions [J]. Clin J Am Soc Nephrol, 2008, 3(3): 876-880.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[9] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[10] 帖璇, 苏晓乐, 王利华. 抗中性粒细胞胞质抗体相关性血管炎治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 345-351.
[11] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要